Photo
May 27, 2022
La Jolla-based Scripps Research will lead a major national effort to develop new antiviral drugs. Photo courtesy Scripps Research
Stories this photo appears in:
Scripps to Lead Major Antiviral Push
PHARMA: $67M NIH Program Includes 16 U.S. Research Institutes
The National Institute of Allergy and Infectious Diseases (NIAID) announced earlier this month (May 18) it was sponsoring a major new antiviral drug development center to be led by La Jolla-based Scripps Research.
